Serious adverse events remain uncommon, though tirzepatide carries a black box warning regarding theoretical thyroid risks identified in animal models
Clinical practice guidelines[20, 21] have recommended the use of SGLT2i in individuals at higher risk of HF, while GLP-1RA may be prioritized in those with T2DM at higher ASCVD risk (calculated 10-year ASCVD risk 10%, Class IIa, level of evidence: B) given their neutral effect on HF hospitalization [22]
While they are not a magic solution for weight loss, they offer meaningful metabolic support that helps patients stay energized, motivated, and on track with their health goals
The knowledge proved immediately practical, allowing him to help formalize the structure of his familys business, laying the foundation for what would become a successful, multi-entity enterprise